NASDAQ:VTL - Vital Therapies News Headlines

$9.52
+0.14 (+1.49 %)
(As of 06/17/2019 02:35 AM ET)
Today's Range
$9.04
Now: $9.52
$9.95
50-Day Range
$9.00
MA: $11.24
$16.28
52-Week Range
$0.15
Now: $9.52
$9.75
Volume53,530 shs
Average Volume21.62 million shs
Market Capitalization$403.36 million
P/E RatioN/A
Dividend YieldN/A
Beta3.51

Headlines

Vital Therapies (NASDAQ VTL) News Headlines

Source:
DateHeadline
The Vistal Gdynia (WSE:VTL) Share Price Has Gained 154%, So Why Not Pay It Some Attention?The Vistal Gdynia (WSE:VTL) Share Price Has Gained 154%, So Why Not Pay It Some Attention?
finance.yahoo.com - June 11 at 8:44 AM
Vital Therapies (VTL) Given Consensus Recommendation of "Hold" by AnalystsVital Therapies (VTL) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 2 at 5:05 AM
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune DiseasesImmunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases
finance.yahoo.com - April 12 at 8:29 PM
Vital Therapies, Inc. Announces Filing of its Form 10-Q for the...Vital Therapies, Inc. Announces Filing of its Form 10-Q for the...
www.nasdaq.com - April 10 at 8:24 PM
Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019
finance.yahoo.com - April 10 at 8:24 PM
How Might the Immunic Combination with Vital Therapies Impact InvestorsHow Might the Immunic Combination with Vital Therapies Impact Investors
finance.yahoo.com - April 10 at 8:53 AM
Vital Therapies +20% on shareholder OK on mergerVital Therapies +20% on shareholder OK on merger
seekingalpha.com - April 5 at 7:48 PM
Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AGVital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG
finance.yahoo.com - April 4 at 8:01 PM
Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AGVital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG
www.globenewswire.com - March 27 at 8:28 AM
Vital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AGVital Therapies Reminds Stockholders to Vote For the Proposed Business Combination With Immunic AG
finance.yahoo.com - March 27 at 8:28 AM
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies StockholdersLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders
www.nasdaq.com - March 25 at 9:17 AM
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Proposed Business Transaction With Immunic AG and All the Related ProposalsLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Proposed Business Transaction With Immunic AG and All the Related Proposals
finance.yahoo.com - March 25 at 9:17 AM
Vital Therapies Announces 2018 Financial ResultsVital Therapies Announces 2018 Financial Results
finance.yahoo.com - March 4 at 7:58 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vital Therapies, Inc. - VTLSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vital Therapies, Inc. - VTL
finance.yahoo.com - February 26 at 6:42 PM
Vital Therapies to acquire Immunic AG in all-stock dealVital Therapies to acquire Immunic AG in all-stock deal
seekingalpha.com - January 8 at 8:24 AM
Form 8-K VITAL THERAPIES INC For: Jan 06 - StreetInsider.comForm 8-K VITAL THERAPIES INC For: Jan 06 - StreetInsider.com
www.streetinsider.com - January 7 at 6:21 PM
Vital Therapies (VTL) to Acquire Outstanding Shares in Immunic - StreetInsider.comVital Therapies (VTL) to Acquire Outstanding Shares in Immunic - StreetInsider.com
www.streetinsider.com - January 7 at 6:21 PM
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease CompanyVital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
finance.yahoo.com - January 7 at 8:16 AM
Vital Therapies Announces Third Quarter 2018 Financial ResultsVital Therapies Announces Third Quarter 2018 Financial Results
finance.yahoo.com - November 8 at 8:21 AM
Vital Therapies: 3Q Earnings SnapshotVital Therapies: 3Q Earnings Snapshot
finance.yahoo.com - November 8 at 8:21 AM
Vital Therapies: An Attractive Opportunity For An Acquirer To Get The ELAD System For Almost FreeVital Therapies: An Attractive Opportunity For An Acquirer To Get The ELAD System For Almost Free
seekingalpha.com - October 22 at 5:21 PM
Vital Therapies (VTL) to Cut Workforce by 80%Vital Therapies (VTL) to Cut Workforce by 80%
www.streetinsider.com - October 11 at 4:51 PM
Vital Therapies to explore strategic alternatives; shares up 8%Vital Therapies to explore strategic alternatives; shares up 8%
seekingalpha.com - October 11 at 4:51 PM
Vital Therapies Provides Strategic UpdateVital Therapies Provides Strategic Update
finance.yahoo.com - October 11 at 4:51 PM
Today’s Research Reports on Stocks to Watch: Tonix Pharmaceuticals and Vital TherapiesToday’s Research Reports on Stocks to Watch: Tonix Pharmaceuticals and Vital Therapies
finance.yahoo.com - October 4 at 8:16 AM
Vital Therapies to Present at the 19th International Liver Support MeetingVital Therapies to Present at the 19th International Liver Support Meeting
finance.yahoo.com - September 29 at 5:09 PM
Who Are Vital Therapies Inc’s (NASDAQ:VTL) Major Shareholders?Who Are Vital Therapies Inc’s (NASDAQ:VTL) Major Shareholders?
finance.yahoo.com - September 20 at 4:55 PM
Raymond James Downgrades Vital Therapies (VTL) to Market PerformRaymond James Downgrades Vital Therapies (VTL) to Market Perform
www.streetinsider.com - September 14 at 8:26 AM
VTL To Dump ELAD System, KRYS Awaits Data Readout In Q4, COOL On WatchVTL To Dump ELAD System, KRYS Awaits Data Readout In Q4, COOL On Watch
www.nasdaq.com - September 13 at 8:27 AM
Today’s Research Reports on Stocks to Watch: Bausch Health Companies and Vital TherapiesToday’s Research Reports on Stocks to Watch: Bausch Health Companies and Vital Therapies
finance.yahoo.com - September 13 at 8:27 AM
Is Vital Therapies Done?Is Vital Therapies Done?
247wallst.com - September 12 at 4:51 PM
Vital Therapies shares dive as liver system fails trialVital Therapies shares dive as liver system fails trial
www.nasdaq.com - September 12 at 8:20 AM
Vital Therapies down 82% as VTL-308 fails to achieve primary and secondary endpoints of improvement in survivalVital Therapies down 82% as VTL-308 fails to achieve primary and secondary endpoints of improvement in survival
seekingalpha.com - September 12 at 8:20 AM
Vital Therapies VTL-308 Fails To Meet Goals; To Stop ELAD Systems DevelopmentVital Therapies' VTL-308 Fails To Meet Goals; To Stop ELAD System's Development
www.nasdaq.com - September 12 at 8:20 AM
Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in SurvivalVital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in Survival
finance.yahoo.com - September 12 at 8:20 AM
Vital Therapies shares slide 86% after biotech says it will scrap treatment for liver failureVital Therapies shares slide 86% after biotech says it will scrap treatment for liver failure
finance.yahoo.com - September 12 at 8:20 AM
3 Biotech Stocks That Could Double Your Money3 Biotech Stocks That Could Double Your Money
finance.yahoo.com - September 8 at 8:18 AM
Why Vital Therapies Is One Of My Two Favorite ShortsWhy Vital Therapies Is One Of My Two Favorite Shorts
seekingalpha.com - August 23 at 5:04 PM
Why Vital Therapies Is One Of My 2 Favorite ShortsWhy Vital Therapies Is One Of My 2 Favorite Shorts
seekingalpha.com - August 23 at 5:04 PM
Vital Therapies +2.8% as Cantor starts at OverweightVital Therapies +2.8% as Cantor starts at Overweight
seekingalpha.com - August 21 at 8:22 AM
Is the Options Market Predicting a Spike in Vital Therapies (VTL) Stock?Is the Options Market Predicting a Spike in Vital Therapies (VTL) Stock?
finance.yahoo.com - August 14 at 5:34 PM
Vital Therapies, Inc. (VTL) CEO Russell Cox on Q2 2018 Results - Earnings Call TranscriptVital Therapies, Inc. (VTL) CEO Russell Cox on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 5:32 PM
Vital Therapies Announces Second Quarter 2018 Financial ResultsVital Therapies Announces Second Quarter 2018 Financial Results
finance.yahoo.com - August 7 at 5:24 PM
Vital Therapies: 2Q Earnings SnapshotVital Therapies: 2Q Earnings Snapshot
finance.yahoo.com - August 7 at 5:24 PM
UPDATE: William Blair Upgrades Vital Therapies (VTL) to OutperformUPDATE: William Blair Upgrades Vital Therapies (VTL) to Outperform
www.streetinsider.com - August 7 at 8:22 AM
William Blair Upgrades Vital Therapies Ahead Of September Liver Failure DataWilliam Blair Upgrades Vital Therapies Ahead Of September Liver Failure Data
finance.yahoo.com - August 6 at 5:34 PM
William Blair Upgrades Vital Therapies (VTL) to OutperformWilliam Blair Upgrades Vital Therapies (VTL) to Outperform
www.streetinsider.com - August 6 at 8:08 AM
Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With WebcastVital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
finance.yahoo.com - July 31 at 5:52 PM
Are Options Traders Betting on a Big Move in Vital Therapies (VTL) Stock?Are Options Traders Betting on a Big Move in Vital Therapies (VTL) Stock?
finance.yahoo.com - June 26 at 5:16 PM
Vital Therapies Joins the Russell 3000 Index®Vital Therapies Joins the Russell 3000 Index®
finance.yahoo.com - June 25 at 8:43 AM
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel